Novartis (NVS) (OTCPK:NVSEF) has announced that its next-generation malaria treatment, KLU156 (GanLum), developed with Swiss ...

New England Biolabs (NEB®) today announces the release of the NEBNext Flu A Integrated Indexing Primer Module (NEB #E3436), ...

Heterozygous deletions of the short arm of chromosome 3 have consistently been found in various types of lung cancer, the shortest region of overlap of the deletions being band 3p21 [1–3]. Therefore, ...

This guide is broken into five steps It involves looking at pricing data spreadsheets The data is available because federal and state officials want consumers to shop around Do you need a hip joint ...

Despite strong evidence for metronidazole, amoebiasis persists as a global burden, highlighting gaps in diagnostics and ...

Alok Dadhich, Chief Business Officer of LifeCell Diagnostics, said "LifeCell envisions a future in which preventive healthcare is a way of life. Our mission is to make early and accurate diagnostics ...

Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...

Novartis NVS reported positive top-line data from a late-stage study of its investigational new malaria treatment candidate, ...

Rift Valley Fever is a mosquito-borne viral disease that primarily affects sheep, goats, cattle and camels, while also ...

This study shows that excitatory cholecystokinin (CCK)-expressing neurons in hippocampal area CA3 influence hippocampal-dependent memory using multiple methods to manipulate excitatory CCK-expressing ...

Simple, Accurate, Affordable Solution for Pharmacogenomics Profiling to Identify Genetic Biomarkers Associated with Drug Response-- --Learn ...

The global Wastewater Surveillance Market, valued at US$0.82 billion in 2024, stood at US$0.88 billion in 2025 and is ...